Tocagen Inc. (NASDAQ: TOCA) and Beijing Apollo Venus Biomedical Technology Limited, an affiliate of ApolloBio Corp. today announced they have ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in the Greater China RegionApril 19, 2018 8:00 AM